GlaxoSmithKline impotent in face of the Viagra challenge

GlaxoSmithKline has given up on its impotence pill, Levitra, in most countries outside the US after it failed to dent sales of Viagra.

The UK's biggest drug maker yesterday sold European and other rights to the product back to its inventor, Bayer of Germany, for €208m (£145m).

Levitra was launched in 2003 but has failed to capture sales from the iconic blue pill which turned male impotence into a multibillion-dollar drug market in the 1990s. It has managed only a poor third in the market for erectile dysfunction medicines, behind Cialis, developed by the US company, Eli Lilly. Levitra works only slightly faster than Viagra and does not last as long as Cialis, which was dubbed "le weekend" in the French market.

Viagra has about 70 per cent of the global market, with Cialis at almost 20 per cent. Bayer admitted last year that sales of Levitra had been disappointing, while GSK showed falling sales of the drug through last year. In the first nine months of 2004, it accounted for just £37m of GSK's £15bn turnover. Some analysts believe about half of Levitra prescriptions were free samples, because competition is so fierce.

GSK and Bayer will continue to co-market Levitra in the US, where television and poster advertising of prescription drugs is allowed and where GSK believes a big marketing push could improve sales. The co-marketing agreement will also continue in Italy, but Bayer will assume sole control of sales in the rest of Europe, Canada and several other countries.

David Stout, the president of GSK's pharmaceutical operations, said: "GSK will continue to be actively involved in marketing the product in the US, Italy and 25 other countries worldwide, and both companies remain firmly committed to its commercial success."

Although the decision to sever the marketing partnership in most countries came at GSK's behest, Bayer said it would enhance its earnings from next year. The company is trying to strengthen its pharmaceuticals business after losing sales of its best-selling medicine, the antibiotic Cipro.

Wolfgang Plischke, the head of Bayer Healthcare's pharmaceuticals division, said buying back Levitra's co-promotion rights "will enhance the group in Europe, Latin America and Asia where we have a strong primary care organisation".

Start your day with The Independent, sign up for daily news emails
ebooks
ebooksAn introduction to the ground rules of British democracy
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Recruitment Genius: Sales Assistant / Buyer

£15000 - £17000 per annum: Recruitment Genius: This company offers a range of ...

Recruitment Genius: Customer Service Advisor

£15000 - £16000 per annum: Recruitment Genius: Customer Service Advisors are r...

SThree: Trainee Recruitment Consultant

£20000 - £25000 per annum + OTE £45K: SThree: SThree were established in 1986....

Recruitment Genius: Compliance Manager

£40000 - £60000 per annum: Recruitment Genius: A Compliance Manager is require...

Day In a Page

Greece debt crisis: What happened to democracy when it’s a case of 'Vote Yes or else'?

'The economic collapse has happened. What is at risk now is democracy...'

If it doesn’t work in Europe, how is it supposed to work in India or the Middle East, asks Robert Fisk
The science of swearing: What lies behind the use of four-letter words?

The science of swearing

What lies behind the use of four-letter words?
The Real Stories of Migrant Britain: Clive fled from Zimbabwe - now it won't have him back

The Real Stories of Migrant Britain

Clive fled from Zimbabwe - now it won’t have him back
Africa on the menu: Three foodie friends want to popularise dishes from the continent

Africa on the menu

Three foodie friends want to popularise dishes from the hot new continent
Donna Karan is stepping down after 30 years - so who will fill the DKNY creator's boots?

Who will fill Donna Karan's boots?

The designer is stepping down as Chief Designer of DKNY after 30 years. Alexander Fury looks back at the career of 'America's Chanel'
10 best statement lightbulbs

10 best statement lightbulbs

Dare to bare with some out-of-the-ordinary illumination
Wimbledon 2015: Heather Watson - 'I had Serena's poster on my wall – now I'm playing her'

Heather Watson: 'I had Serena's poster on my wall – now I'm playing her'

Briton pumped up for dream meeting with world No 1
Wimbledon 2015: Nick Bollettieri - It's time for big John Isner to produce the goods to go with his thumping serve

Nick Bollettieri's Wimbledon Files

It's time for big John Isner to produce the goods to go with his thumping serve
Dustin Brown: Who is the tennis player who knocked Rafael Nadal out of Wimbeldon 2015?

Dustin Brown

Who is the German player that knocked Nadal out of Wimbeldon 2015?
Ashes 2015: Damien Martyn - 'England are fired up again, just like in 2005...'

Damien Martyn: 'England are fired up again, just like in 2005...'

Australian veteran of that Ashes series, believes the hosts' may become unstoppable if they win the first Test
Tour de France 2015: Twins Simon and Adam Yates have a mountain to climb during Tour of duty

Twins have a mountain to climb during Tour of duty

Yates brothers will target the steepest sections in bid to win a stage in France
John Palmer: 'Goldfinger' of British crime was murdered, say police

Murder of the Brink’s-MAT mastermind

'Goldfinger' of British crime's life ended in a blaze of bullets, say police
Forget little green men - aliens will look like humans, says Cambridge University evolution expert

Forget little green men

Leading evolutionary biologist says aliens will look like humans
The Real Stories of Migrant Britain: An Algerian scientist adjusts to life working in a kebab shop

The Real Stories of Migrant Britain

An Algerian scientist struggles to adjust to her new life working in a Scottish kebab shop
Bodyworlds museum: Dr Gunther von Hagens has battled legal threats, Parkinson's disease, and the threat of bankruptcy

Dying dream of Doctor Death

Dr Gunther von Hagens has battled legal threats, Parkinson's disease, and the threat of bankruptcy